FDA Grants Early Access to Promising Drug for Pancreatic Cancer

FDA Grants Early Access to Promising Drug for Pancreatic Cancer

Patients with one of the deadliest cancers have been pleading for this yet-unapproved treatment that may prolong their lives.

Original Source

Read the full article at Seattletimes →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.